2025-09-09T12:38:45-05:00 2024-12-31 390974031 WEGNER CPAS LLP 419 N LEE ST ALEXANDRIA VA 223142301 990 2024-01-01 131691693 ASTHMA AND ALLERGY FOUNDATION OF AMERICA INC ASTH 8007278462 1400 CRYSTAL DRIVE 660 ARLINGTON VA 22202 KENNETH MENDEZ CEO/PRESIDENT 8007278462 2025-09-09 1 1 ADAM KUCZYNSKI CPA P01560606 7035190990 2025-09-08 2024 2025-03-06 01:10:19Z X KENNETH MENDEZ 1400 CRYSTAL DRIVE 660 ARLINGTON VA 22202 7267013 0 X AAFA.ORG X 1953 NY A NATIONAL VOLUNTARY HEALTH ORGANIZATION PROVIDING EDUCATION, INFORMATION, SERVICES & RESEARCH. 22 22 26 23 0 0 4808966 4651333 898280 1257073 109788 280358 6442 10675 5823476 6199439 328750 419190 0 0 3455675 3517499 0 0 333265 2017447 1971593 5801872 5908282 21604 291157 3597009 3525089 812439 505516 2784570 3019573 X THE ASTHMA AND ALLERGY FOUNDATION OF AMERICA, INC (THE FOUNDATION), A NOT-FOR-PROFIT FOUNDED IN 1953, IS DEDICATED TO SAVING LIVES AND REDUCING THE BURDEN OF DISEASE FOR PEOPLE WITH ASTHMA AND ALLERGIES THROUGH SUPPORT, ADVOCACY, EDUCATION AND RESEARCH. 0 0 2024670 327500 1257073 PUBLIC INFORMATION AND PATIENT, FAMILY, COMMUNITY SUPPORT:PROMOTE DISEASE AWARENESS CAMPAIGNS AND ISSUE PUBLIC HEALTH ANNOUNCEMENTS INCLUDING FOOD RECALLS, EMERGENCY AIR QUALITY INFORMATION, AND ALERTS FOR SEVERE WEATHER EVENTS THAT MAY AFFECT ASTHMA AND ALLERGY MANAGEMENT. PROVIDE DIGITAL AND PRINTED MATERIALS FOR PATIENTS, HEALTH CARE PROVIDERS, SCHOOLS, AND HEALTH DEPARTMENTS. ESTABLISH STANDARDS AND PROVIDE INFORMATION ON PRODUCTS THAT HAVE EARNED THE ASTHMA & ALLERGY FRIENDLY CERTIFICATION. PROVIDE DISEASE MANAGEMENT SUPPORT TO PATIENTS AND CAREGIVERS THROUGH PRIVATE ONLINE COMMUNITIES, REGIONAL CHAPTERS, COLLABORATIONS WITH HOSPITALS AND CLINICS, FREE ASK-THE-ALLERGIST SERVICE, TOLL FREE INFORMATION LINE, LOCAL EVENTS, AND SOCIAL MEDIA. TRAINED STAFF PROVIDE EMOTIONAL, MENTAL, AND SOCIAL SUPPORT AS WELL AS INFORMATION TO COMPLEMENT THEIR HEALTH CARE. OFFER TECHNICAL AND FINANCIAL SUPPORT TO COMMUNITY-BASED ORGANIZATIONS. 1401521 0 0 ADVOCACY:EVALUATE FEDERAL, STATE, COUNTY, AND MUNICIPAL LEGISLATION, POLICIES, AND REGULATORY ACTIONS THAT AFFECT PEOPLE WITH ASTHMA AND ALLERGIC CONDITIONS. TRANSLATE LEGISLATIVE REVIEWS FOR PATIENTS, CLINICIANS, AND OTHER STAKEHOLDERS BY PROVIDING SUMMARIES OR REPORTS. COLLABORATE WITH COALITIONS, COMMUNITY GROUPS, AND OTHER NON-PROFIT ORGANIZATIONS TO SUPPORT HEALTHY LIVING FOR PEOPLE WITH ASTHMA AND ALLERGIES. 780955 0 0 EDUCATION FOR HEALTH CARE PROFESSIONALS, PATIENTS, AND CAREGIVERS:OFFER ACCREDITED, CONTINUING EDUCATION FOR HEALTH CARE PROFESSIONALS (DOCTORS, PRACTITIONERS, NURSES, RESPIRATORY THERAPISTS, ASTHMA EDUCATORS, AND COMMUNITY HEALTH WORKERS) ON ASTHMA AND ALLERGY-RELATED TOPICS. PROVIDE FREE PATIENT AND CAREGIVER EDUCATION THROUGH INFORMATION PACKETS AND BOOKLETS, WEBINARS, PODCASTS, AND ONLINE COURSES. SUPPORT A NATIONAL NETWORK OF ASTHMA PROGRAMS AND EDUCATORS. OFFER ASTHMA EDUCATION PROGRAMS TO HEALTH DEPARTMENTS. 535770 91690 0 PATIENT-CENTERED RESEARCH:INCORPORATE PATIENT PERSPECTIVES AND PREFERENCES INTO THE DESIGN, CONDUCT, AND DISSEMINATION OF ASTHMA AND ALLERGY RESEARCH TO IMPROVE HEALTH OUTCOMES AND INFORM DECISION-MAKING. DEVELOP INTERVENTIONS THAT PRIORITIZE WHAT MATTERS MOST TO PATIENTS AND THEIR FAMILIES. RECRUIT CLINICAL TRIAL PARTICIPANTS AS WELL AS PATIENT ADVISORS FOR PATIENT-FOCUSED DRUG DEVELOPMENT. COLLECT AND ANALYZE PATIENT-REPORTED OUTCOMES; PATIENT EXPERIENCE, BEHAVIORS, PREFERENCES, KNOWLEDGE; REAL-WORLD EVIDENCE; HEALTH CARE CLAIMS DATA; AND OTHER DATA. TRANSLATE RESEARCH FINDINGS TO PATIENTS, CLINICIANS, AND OTHER STAKEHOLDERS. PUBLISH IMPACT AND BURDEN OF DISEASE REPORTS. PUBLISH MANUSCRIPTS, ABSTRACTS, WHITE PAPERS, AND POSTERS. 535770 91690 0 4742916 1 1 0 1 0 0 0 0 0 1 1 1 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 18 0 26 1 0 0 0 0 0 0 0 0 0 0 0 0 X 22 22 0 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT DE FL GA HI ID IL IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC TN TX UT VA WA WV WI WY X X KENNETH MENDEZ 8007278462 1400 CRYSTAL DRIVE STE 660 ARLINGTON VA 22202 RITESH PATEL CHAIR 2.00 X X 0 0 0 KELLI WOOD CROSS SECRETARY 2.00 X X 0 0 0 RICHARD MURRAY IMMEDIATE PAST CHAIR 2.00 X X 0 0 0 MITCHELL GRAYSON TREASURER & FINANCE CHAIR 2.00 X X 0 0 0 SARBJIT SAINI THRU JULY 2024 VICE CHAIR, MEDICAL-SCIENTIFIC COUNCIL 2.00 X 0 0 0 MARY ELLEN CONLEY CHAIR OF COMMUNITY RELATIONS 2.00 X 0 0 0 PRUE FITZPATRICK CHAIR OF POLICY & ADVOCACY 2.00 X 0 0 0 LYNN HANESSIAN CHAIR OF DEVELOPMENT 2.00 X 0 0 0 MONICA E RANDALL CHAIR OF AD HOC STRATEGY 2.00 X 0 0 0 PHYLLIS ARTHUR CHAIR OF AUDIT 2.00 X 0 0 0 GORDON BUZBY CHAIR OF CERTIFICATION 2.00 X 0 0 0 JACOB HELLER GENERAL COUNSEL 2.00 X 0 0 0 JODI DANIEL DIRECTOR 1.00 X 0 0 0 MEIGHAN GIRGUS VAFA DIRECTOR 1.00 X 0 0 0 EVALYN GRANT DIRECTOR 1.00 X 0 0 0 PETER LOUPOS DIRECTOR 1.00 X 0 0 0 EMMANUEL MAHLIS DIRECTOR 1.00 X 0 0 0 KATHERINE LAI DIRECTOR 1.00 X 0 0 0 LAWRENCE SCHWARTZ DIRECTOR 1.00 X 0 0 0 JAMES FLOOD DIRECTOR 1.00 X 0 0 0 JERRY M SHIER DIRECTOR 1.00 X 0 0 0 FOLASHADE FARRI DIRECTOR 1.00 X 0 0 0 JAMES C DOCKERY DIRECTOR 1.00 X 0 0 0 KENNETH MENDEZ CEO & PRESIDENT 40.00 X 425505 0 45322 MELANIE CARVER CHIEF MISSIONS OFFICER 40.00 X 289946 0 29283 SANAZ EFTEKHARI CHIEF BUSINESS DEVELOPMENT OFFICER & VP, RESEARCH 40.00 X 260314 0 3313 KATHRYN PRZYWARA VP, COMMUNITY 40.00 X 153404 0 13260 QINGXIN CAI CONTROLLER (FROM APR 2024) 40.00 X 116799 0 2942 KIMBERLY RAFFERTY MARKETING & COMMUNICATIONS PRODUCTION DIRECTOR 40.00 X 115146 0 10139 JENNA RIEMENSCHNEIDER VICE PRESIDENT OF ADVOCACY AND POLICY 40.00 X 122098 0 10042 ELISA ZIZZA DIRECTOR OF DEVELOPMENT 40.00 X 107916 0 6471 NICOLE GAGHAN CREATIVE DIRECTOR 40.00 X 101706 0 12615 1692834 0 133387 10 0 1 0 SPECTRUM FINANCIAL SERVICES 8614 WESTWOOD CENTER DRIVE SUITE 7 VIENNA VA 22182 ACCOUNTING AND RECRUITMENT SERVICES 183796 1 220692 4430641 4651333 CERTIFICATIONS 900099 1257073 1257073 1257073 68513 68513 1279419 1067125 449 212294 -449 211845 211845 10675 10675 10675 6199439 1257073 0 291033 X 419190 419190 1220347 954025 175652 90670 1828458 1429425 263181 135852 67873 53061 9769 5043 200365 156638 28840 14887 200456 156710 28852 14894 51256 51256 11932 11932 849305 730290 104495 14520 44189 44189 125048 81738 36265 7045 88569 76479 7015 5075 186256 139928 33091 13237 136972 115830 15209 5933 49945 23132 13600 13213 21065 16231 3274 1560 50250 38925 7587 3738 DUES AND SUBSCRIPTIONS 308108 281772 22793 3543 48698 25353 19290 4055 5908282 4742916 832101 333265 865768 143481 130962 454869 463312 554253 23762 134375 21298 10231 104353 98222 88983 51686 31912 37297 1625365 1304283 86018 607592 244259 180486 3597009 3525089 482966 350701 73700 0 255773 154815 812439 505516 X 414066 533151 2370504 2486422 2784570 3019573 3597009 3525089 291157 -56154 0 X 0 1 X 1 0 X 2205926 4861216 3876510 4808966 4651332 20403950 2205926 4861216 3876510 4808966 4651332 20403950 9796488 10607462 53392 95658 76536 48000 68513 342099 20746049 6080491 0.51130 0.53250 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 13500 9556 23056 5885226 5908282 445414 111354 0 0 397196 438113 440094 445414 1720817 2581226 7438 12705 17736 23056 60935 99299 109528 110024 111354 430205 645308 7438 10000 10000 13500 40938 376451 24106 400557 353917 22534 376451 395760 -41843 353917 384234 17926 6400 395760 371854 18780 6400 384234 0.00000 0.39944 0.60056 0 0 56985 45233 11752 31998 6453 25545 37297 CASH AND CASH EQUIVALENTS 607592 F 607592 DEFERRED COMPENSATION ASSET 154815 DEPOSITS 25671 180486 DEFERRED COMPENSATION LIABILITY 154815 154815 6466270 -56154 334917 -11932 266831 6199439 0 6199439 6231267 334917 334917 5896350 11932 11932 5908282 PART V, LINE 4: THE FOUNDATION HAS A DONOR-RESTRICTED ENDOWMENT FUND ESTABLISHED FOR THE PURPOSE OF SUPPORTING RESEARCH BY PHYSICAN-SCIENTISTS IN THE FIELD OF ALLERGY AND IMMUNOLOGY. PART XI, LINE 2D - OTHER ADJUSTMENTS: INVESTMENT MANAGEMENT FEES REPORTED ON FORM 990, PART IX, LINE 11F -11,932. 1 AIRNYC 349 E 149TH ST RM 609 BRONX NY 10451 132612524 501(C)(3) 93750 0 HEAL INNOVATION PROGRAM MICHIGAN CHAPTER ASTHMA AND ALLERGY FOUNDATION OF AMERICA 26111 WEST 14 MILE STE LL1 FRANKLIN MI 48025 382534175 501(C)(3) 93750 0 HEAL INNOVATION PROGRAM YOUNG TEEN ASTHMA & WELLNESS CAMP INC 1524 SHADES CREST RD BIRMINGHAM AL 35226 861585197 501(C)(3) 65000 0 HEAL INNOVATION PROGRAM UNIVERSITY OF COLORADO DENVER 1201 LARIMER ST DENVER CO 80204 846000555 GOVT 47000 0 FOOD ALLERGY DECISION AID RESEARCH PROJECT BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA BCM 225 HOUSTON TX 77030 741613878 44690 0 FOOD ALLERGY DECISION AID RESEARCH PROJECT THE GENERAL HOSPITAL CORPORATION 55 FRUIT ST BOSTON MA 02114 042697983 501(C)(3) 28750 0 HEAL INNOVATION PROGRAM ALASKA CHAPTER ASTHMA AND ALLERGY FOUNDATION OF AMERICA PO BOX 201927 ANCHORAGE AK 99520 920176309 501(C)(3) 10000 0 HEAL INNOVATION PROGRAM HEALTH PROMOTION COUNCIL 1500 MARKET ST PHILADELPHIA PA 19102 232182113 501(C)(3) 31250 0 HEAL INNOVATION PROGRAM 7 1 PART I, LINE 2: RECIPIENTS OF EACH GRANT SIGNED A MEMORANDUM OF UNDERSTANDING WITH AAFA AND OTHER DOMESTIC PARTNERS. A COUNCIL OF REPRESENTATIVES FROM AAFA AND EACH PARTNER WAS FORMED TO PROVIDE OVERSIGHT FOR THE GRANT FUNDS. X 0 0 0 0 0 0 0 0 0 KENNETH MENDEZ CEO & PRESIDENT 403442 0 22063 0 0 0 26571 0 18751 0 470827 0 0 0 MELANIE CARVER CHIEF MISSIONS OFFICER 277946 0 12000 0 0 0 14021 0 15262 0 319229 0 0 0 SANAZ EFTEKHARI CHIEF BUSINESS DEVELOPMENT OFFICER & 248314 0 12000 0 0 0 0 0 3313 0 263627 0 0 0 KATHRYN PRZYWARA VP, COMMUNITY 153404 0 0 0 0 0 7760 0 5500 0 166664 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FEDERAL FORM 990, ONCE REVIEWED BY THE FOUNDATION'S ACCOUNTANTS, IS THEN FORWARDED TO THE FOUNDATION'S CEO AND PRESIDENT FOR REVIEW. WHEN SECONDARY REVIEW HAS BEEN COMPLETED, AND THE FEDERAL FORM 990 HAS BEEN APPROPRIATELY UPDATED OR CORRECTED, IT IS PRESENTED TO THE EXECUTIVE COMMITTEE FOR THEIR REVIEW AND APPROVAL. IT IS THEN SHARED WITH THE FULL BOARD OF DIRECTORS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY AND DISCLOSURE FORM IS DISTRIBUTED TO THE STAFF, WHICH INCLUDES OFFICERS, KEY EMPLOYEES AND HIGHEST COMPENSATED EMPLOYEES AND TO THE FULL BOARD OF DIRECTORS ANNUALLY FOR SIGNATURE REVIEW. ANY REPORTABLE CONFLICTS ARE REPORTED ON DISCLOSURE FORMS AND AT BOARD MEETINGS. DURING THE COURSE OF BOARD MEETING DISCUSSIONS, IF AREAS ARISE WHICH MAY CREATE A CONFLICT, OR THE APPEARANCE OF A CONFLICT OF INTEREST, THE BOARD OF DIRECTORS IS REMINDED OF THEIR RESPONSIBILITY TO RECUSE THEMSELVES FROM PARTICIPATION OF THE SAID MATTER. FORM 990, PART VI, SECTION B, LINE 15A ANNUALLY DURING THE BUDGET PREPARATION PROCESS, THE FINANCE COMMITTEE REVIEWS THE SALARY OF THE CEO AND PRESIDENT, AND COMPARES THE PROPOSED SALARY TO LIKE ORGANIZATIONS, POSITIONS AND GEOGRAPHIC AREAS TO RECOMMEND BUDGET APPROVAL TO THE FULL BOARD OF DIRECTORS. THE CEO AND PRESIDENT'S COMPENSATION IS APPROVED BY THE FULL BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 THE CONFLICT OF INTEREST POLICY, WHISTLEBLOWER POLICY, FINANCIAL STATEMENTS AND THE FEDERAL FORM 990 ARE AVAILABLE ON THE FOUNDATION'S WEBSITE AT WWW.AAFA.ORG. THEY MAY ALSO BE OBTAINED BY REQUEST FROM THE CEO AND PRESIDENT. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 730,290. MANAGEMENT AND GENERAL EXPENSES 104,495. FUNDRAISING EXPENSES 14,520. TOTAL EXPENSES 849,305.